Regulators of Metastasis Modulate the Migratory Response to Cell Contact under Spatial Confinement.
The breast tumor microenvironment (TMEN) is a unique niche where protein fibers help to promote invasion and metastasis. Cells migrating along these fibers are constantly interacting with each other. How cells respond to these interactions has important implications. Cancer cells that circumnavigate or slide around other cells on protein fibers take a less tortuous path out of the primary tumor; conversely, cells that turn back upon encountering other cells invade less efficiently. The contact response of migrating cancer cells in a fibrillar TMEN is poorly understood. Here, using high-aspect ratio micropatterns as a model fibrillar platform, we show that metastatic cells overcome spatial constraints to slide effectively on narrow fiber-like dimensions, whereas nontransformed MCF-10A mammary epithelial cells require much wider micropatterns to achieve moderate levels of sliding. Downregulating the cell-cell adhesion protein, E-cadherin, enables MCF-10A cells to slide on narrower micropatterns; meanwhile, introducing exogenous E-cadherin in metastatic MDA-MB-231 cells increases the micropattern dimension at which they slide. We propose the characteristic fibrillar dimension (CFD) at which effective sliding is achieved as a metric of sliding ability under spatial confinement. Using this metric, we show that metastasis-promoting genetic perturbations enhance cell sliding and reduce CFD. Activation of ErbB2 combined with downregulation of the tumor suppressor and cell polarity regulator, PARD3, reduced the CFD, in agreement with their cooperative role in inducing metastasis in vivo. The CFD was further reduced by a combination of ErbB2 activation and transforming growth factor β stimulation, which is known to enhance invasive behavior. These findings demonstrate that sliding is a quantitative property and a decrease in CFD is an effective metric to understand how multiple genetic hits interact to change cell behavior in fibrillar environments. This quantitative framework sheds insights into how genetic perturbations conspire with fibrillar maturation in the TMEN to drive the invasive behavior of cancer cells.
Department of Chemical Engineering, Northeastern University, Boston, Massachusetts.
Daniel F
DF
Milano
Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada.
Nicholas A
NA
Ngai
Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada; Beth Israel Deaconess Medical Centre, Harvard Medical School, Boston, Massachusetts. Electronic address: smuthusw@bidmc.harvard.edu.
Senthil K
SK
Muthuswamy
Department of Chemical Engineering, Northeastern University, Boston, Massachusetts; Department of Bioengineering, Northeastern University, Boston, Massachusetts. Electronic address: a.asthagiri@neu.edu.
Anand R
AR
Asthagiri
D048868:Adaptor Proteins, Signal Transducing; D001943:Breast Neoplasms / Q000473:pathology*; D015820:Cadherins / Q000172:deficiency / Q000235:genetics; D018797:Cell Cycle Proteins / Q000378:metabolism; D045744:Cell Line, Tumor; D002465:Cell Movement / Q000187:drug effects; D055785:Gene Knockdown Techniques; D006801:Humans; D008565:Membrane Proteins / Q000378:metabolism; D008954:Models, Biological; D009362:Neoplasm Metastasis; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism; D016212:Transforming Growth Factor beta / Q000494:pharmacology; D059016:Tumor Microenvironment / Q000187:drug effects
D048868:Adaptor Proteins, Signal Transducing; D015820:Cadherins; D018797:Cell Cycle Proteins; D008565:Membrane Proteins; D018719:Erb-b2 Receptor Tyrosine Kinases; D016212:Transforming Growth Factor beta; C509689:PARD3 protein, human; C508053:ERBB2 protein, human